首页> 外文OA文献 >Serial follow-up of presurgical treatment using pasireotide long-acting release with or without octreotide long-acting release for naïve active acromegaly

【2h】

Serial follow-up of presurgical treatment using pasireotide long-acting release with or without octreotide long-acting release for naïve active acromegaly

机译：使用pasireotide长效释放的术前随访，有或没有奥曲肽长效释放治疗原发性肢端肥大症

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Jan-Shun Chang; Ham-Min Tseng; Tien-Chun Chang;
展开▼
作者单位

展开▼
年度 2016
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Safety and tolerability of pasireotide long-acting release in acromegaly-results from the acromegaly, open-label, multicenter, safety monitoring program for treating patients who have a need to receive medical therapy (ACCESS) study [J] . Fleseriu Maria, Rusch Elisha, Geer Eliza B. Endocrine. . 2017,第1期

机译：患者患者治疗患者患者的骨质疗化长效释放的安全性和可耐受性 - 治疗需要接受医疗治疗的患者（访问）研究
2. Effect of presurgical long-acting octreotide treatment in acromegaly patients with invasive pituitary macroadenomas: a prospective randomized study [J] . Ming Shen, Xuefei Shou, Yongfei Wang, Endocrine journal . 2010,第12期

机译：术前长效奥曲肽治疗肢端肥大症并发垂体腺瘤的疗效：一项前瞻性随机研究
3. Effect of presurgical long-acting octreotide treatment in acromegaly patients with invasive pituitary macroadenomas: a prospective randomized study [J] . Jinsong Wu, Ming Shen, Shiqi Li, Endocrine journal . 2010,第12期

机译：术前长效奥曲肽治疗肢端肥大症并发垂体腺瘤的疗效：一项前瞻性随机研究
4. A MICROPOROUS CHITOSAN/COLLAGEN COMPOSITE ENCAPSULATED SMALL TUBE OF NANOPOROUS ANODIC ALUMINUM OXIDE FOR LONG-ACTING DRUG RELEASE [C] . Bao-Ying Lee, Ching-Wen Li, Gou-Jen Wang ASME international mechanical engineering congress and exposition . 2016

机译：微孔壳聚糖/胶原蛋白复合包封的纳米多孔阳极氧化铝小管用于长效药物释放
5. The role of actively and passively released extracellular eDNA as genetic resource in monoculture and binary Acinetobacter baylyi ADP1 biofilms. [D] . Jin, Yujie. 2013

机译：主动和被动释放胞外eDNA作为遗传资源在单培养和二元不动杆菌ADP1生物膜中的作用。
6. Safety and tolerability of pasireotide long-acting release in acromegaly—results from the acromegaly open-label multicenter safety monitoring program for treating patients who have a need to receive medical therapy (ACCESS) study [O] . Maria Fleseriu, Elisha Rusch, Eliza B. Geer -1

机译：Pasireotide长效释放在肢端肥大症中的安全性和耐受性-肢端肥大症开放标签多中心安全监测计划的结果用于治疗需要接受药物治疗（ACCESS）研究的患者
7. Safety and tolerability of pasireotide long-acting release in acromegaly—results from the acromegaly, open-label, multicenter, safety monitoring program for treating patients who have a need to receive medical therapy (ACCESS) study [O] . Maria Fleseriu, null null, Elisha Rusch, 2016

机译：Pasireotide长效释放在肢端肥大症中的安全性和耐受性-肢端肥大症，开放标签，多中心安全监测计划的结果，用于治疗需要接受药物治疗（ACCESS）研究的患者

Serial follow-up of presurgical treatment using pasireotide long-acting release with or without octreotide long-acting release for naïve active acromegaly

著录项

相似文献

相关主题

期刊订阅